Article
Immunology
Kaan Kamali, Moritz Schmelzle, Can Kamali, Philipp Brunnbauer, Katrin Splith, Annekatrin Leder, Nadja Berndt, Karl-Herbert Hillebrandt, Nathanael Raschzok, Linda Feldbruegge, Matthaeus Felsenstein, Joseph Gassner, Paul Ritschl, Georg Lurje, Wenzel Schoening, Christian Benzing, Johann Pratschke, Felix Krenzien
Summary: Peripheral liver-derived extracellular particles (EP) in blood plasma are used non-invasively to diagnose acute cellular rejection (ACR) following liver transplantation. Through experiments and clinical analysis, EPs are found to have a high accuracy in predicting ACR in LT patients.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Multidisciplinary Sciences
Jennifer K. Frediani, Yara S. Beyh, Nitika Gupta, Adrianna L. Westbrook, Rebecca Cleeton, Maria Cordero, Albert Hernandez, ViLinh Tran, Dean P. Jones, Miriam B. Vos
Summary: In this study, high resolution metabolic profiling was conducted on plasma samples from pediatric liver transplant patients. Over 500 significant metabolites related to acute liver transplant rejection were identified. Bile acid biosynthesis and tryptophan metabolism were found to be the main differentiating pathways, with tryptophan also being associated with liver enzymes and steroid use. These findings suggest the potential for developing a non-invasive biomarker-based rejection screening test.
SCIENTIFIC REPORTS
(2022)
Article
Immunology
Xiangchao Ding, Sheng Le, Ke Wang, Yunshu Su, Shanshan Chen, Chuangyan Wu, Jiuling Chen, Anchen Zhang, Jiahong Xia
Summary: CD4+T cell-mediated acute rejection is a major factor affecting the early survival of transplanted organs. Nr4A1, a transcription factor with important roles in CD4+T cell apoptosis and differentiation, may play a critical role in transplant rejection. Csn-B, a naturally occurring agonist of Nr4A1, attenuates acute transplant rejection by modulating the CD4+T lymphocyte response, inducing non-Treg apoptosis, promoting Treg cell differentiation, and directly targeting Nr4A1 in CD4+T cells.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2022)
Article
Gastroenterology & Hepatology
Tiong Y. Lim, Elena Perpinan, Maria-Carlota Londono, Rosa Miquel, Paula Ruiz, Ada S. Kurt, Elisavet Kodela, Amy R. Cross, Claudia Berlin, Joanna Hester, Fadi Issa, Abdel Douiri, Felix H. Volmer, Richard Taubert, Evangelia Williams, Anthony J. Demetris, Andrew Lesniak, Gilbert Bensimon, Juan Jose Lozano, Marc Martinez-Llordella, Tim Tree, Alberto Sanchez-Fueyo
Summary: This study investigated the role of low-dose IL-2 (LDIL-2) in maintaining liver allograft tolerance. The results showed that LDIL-2 expanded circulating regulatory T cells (Tregs) but failed to effectively suppress antigen-specific immune responses and promote the accumulation of intrahepatic Tregs. Furthermore, LDIL-2 induced a liver transcriptional response even before immunosuppression weaning. The study was terminated after the first 6 participants failed to reach the primary endpoint, requiring reinstitution of immunosuppression.
JOURNAL OF HEPATOLOGY
(2023)
Article
Immunology
Hao Wang, Chenxuan Li, Zhiwei Xiong, Ting Li
Summary: A study found that luteolin (LUT), a natural component, can significantly protect the structure and function of liver grafts, prolong recipient rat survival, ameliorate T cell infiltration, and downregulate proinflammatory cytokines. LUT also inhibits CD4+ T cell proliferation and Th cell differentiation, while increasing the proportion of Tregs, which is crucial for its immunosuppressive effect. This discovery may have important implications for improving immunosuppressive regimens for organ transplantation.
INTERNATIONAL IMMUNOPHARMACOLOGY
(2023)
Article
Multidisciplinary Sciences
Wouter W. Woud, Dennis A. Hesselink, Martin J. Hoogduijn, Carla C. Baan, Karin Boer
Summary: Extracellular vesicles (EVs) are tissue-specific particles containing valuable diagnostic information. This study assesses the applicability of a calibrated Imaging Flow Cytometry (IFCM)-based methodology to directly detect and characterize tissue-specific EV subsets in clinical kidney transplantation.
SCIENTIFIC REPORTS
(2022)
Article
Gastroenterology & Hepatology
George V. Mazariegos, Benjamin L. Shneider, Eyal Shemesh, Deborah Schady, Hector Melin-Aldana, Soo-Jin Cho, Ravinder Anand, Jinson Erinjeri, Rachel Annunziato, Miguel Reyes-Mugica
Summary: The study evaluated interrater reliability of readings of rejection in liver transplant clinical trials using digitized slides, showing substantial disagreement initially among experienced pathologists but improved reliability with a unique study-specific procedure. This suggests the potential for such procedures to increase reliability in histopathologic determinations in future research and possibly in clinical settings.
LIVER TRANSPLANTATION
(2021)
Article
Immunology
Brian Shaw, Jaclyn R. Espinosa, Linda Stempora, Allison Miller, Bartley Adams, Allan D. Kirk
Summary: The study reveals that CD57(+)PD1(-) CD4 T cells are associated with age and CMV infection both before and after transplantation. These cells are unable to replicate on their own but proliferate in the presence of unsorted PBMCs in a contact-independent manner. Stimulation causes these cells to upregulate activation markers and potentially change their CD57/PD1 expression, with PD1 upregulation accentuated by rapamycin but prevented by tacrolimus.
JOURNAL OF IMMUNOLOGY
(2021)
Review
Immunology
Xingqiang Lai, Xin Zheng, James M. Mathew, Lorenzo Gallon, Joseph R. Leventhal, Zheng Jenny Zhang
Summary: Despite advances in post-transplant management, the long-term survival rate of kidney grafts and patients has not improved significantly, as around four in ten transplants fail within ten years due to CKTR. Early detection and effective treatments for CKTR remain challenges, while the development of high throughput biotechnologies offers potential for rapid identification of new biomarkers for diagnosis. Emerging novel therapeutic strategies hold promise for improving long-term graft and patient survival.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Health Care Sciences & Services
Hongmei Jiang, Hui Guo, Bo Yang, Yuanyuan Zhao, Lai Wei, Zhishui Chen, Dong Chen
Summary: This case series explores the characteristics and outcomes of acute AMR in liver transplant recipients with autoimmune liver disease (ALD). The incidence of acute AMR in ALD patients was higher compared to non-ALD recipients. Individualized therapies based on clinical manifestations resulted in good prognoses for most patients.
JOURNAL OF PERSONALIZED MEDICINE
(2023)
Article
Immunology
Zhe Yang, Fei Han, Tao Liao, Haofeng Zheng, Zihuan Luo, Maolin Ma, Jiannan He, Lei Li, Yongrong Ye, Rui Zhang, Zhengyu Huang, Yannan Zhang, Qiquan Sun
Summary: Artemisinin demonstrates significant immunosuppressive effects in rat cardiac transplantation model, attenuating rejection reactions and prolonging allograft survival. By targeting multiple effector cells, artemisinin effectively reduces T cell-mediated rejection and antibody-mediated rejection, showing potential for clinical use in transplant rejection prevention.
FRONTIERS IN IMMUNOLOGY
(2021)
Article
Gastroenterology & Hepatology
Hao Wang, Zheng-Lu Wang, Sai Zhang, De-Jun Kong, Rui-Ning Yang, Lei Cao, Jian-Xi Wang, Sei Yoshida, Zhuo-Lun Song, Tao Liu, Shun-Li Fan, Jia-Shu Ren, Jiang-Hong Li, Zhong-Yang Shen, Hong Zheng
Summary: This study investigated the regulatory effect of continuous capecitabine (CAP) on cell apoptosis and the mechanism of anti-rejection. The results showed that CAP can inhibit acute graft rejection by inducing CD3(+) T cell ferroptosis, making it an effective immunosuppressive agent after liver transplantation.
WORLD JOURNAL OF GASTROENTEROLOGY
(2023)
Article
Genetics & Heredity
Wenjing Wang, Wen Li, Li Cao, Bo Wang, Chang Liu, Yannan Qin, Bo Guo, Chen Huang
Summary: Acute rejection (AR) is a common and serious complication of liver transplantation (LT). This study identified serum extracellular vesicle (EV) microRNAs (miRNAs) as potential biomarkers for AR in LT patients. The results showed that miR-223 and let-7e-5p were up-regulated, while miR-199a-3p was down-regulated, in AR patients compared to non-AR patients. These miRNAs can serve as promising diagnostic biomarkers for AR in patients subjected to liver transplant.
FRONTIERS IN GENETICS
(2022)
Article
Gastroenterology & Hepatology
Sandy Feng, John C. Bucuvalas, George Mazariegos, John C. Magee, Alberto Sanchez-Fueyo, Katharine M. Spain, Andrew Lesniak, Sai Kanaparthi, Emily Perito, Veena L. Venkat, Bryna E. Burrell, Estella M. Alonso, Nancy D. Bridges, Edward Doo, Nitika A. Gupta, Ryan W. Himes, David Ikle, Annette M. Jackson, Steven J. Lobritto, Juan Jose Lozano, Mercedes Martinez, Vicky L. Ng, Elizabeth B. Rand, Averell H. Sherker, Shikha S. Sundaram, Yumirle P. Turmelle, Michele Wood-Trageser, Anthony J. Demetris
Summary: The study found that 37.5% of stable long-term pediatric liver transplant recipients were operationally tolerant, with rejection occurring in those who did not achieve operational tolerance after immunosuppression withdrawal. Liver histology did not deteriorate over the four-year period for both tolerant and nontolerant subjects, indicating the potential benefits of immunosuppression minimization.
Article
Infectious Diseases
Lorenzzo Lyrio Stringari, Luciana Polaco Covre, Flavia Dias Coelho da Silva, Vivian Leite de Oliveira, Maria Carolina Campana, David Jamil Hadad, Moises Palaci, Padmini Salgame, Reynaldo Dietze, Daniel Claudio de Oliveira Gomes, Rodrigo Ribeiro-Rodrigues
Summary: The study demonstrates an increase in the frequency of regulatory T cells in patients with tuberculosis and latent infection, affecting Th-1 responses and reducing in vitro bactericidal activity. This suggests that Tregs may restrict host anti-mycobacterial immunity, contributing to disease progression and pathogen persistence.
PLOS NEGLECTED TROPICAL DISEASES
(2021)